Gene Synthesis Market to Grow with a CAGR of 9.24% through 2028
Rising Adoption Of Gene Therapy and Increased
Prevalence Of Chronic Infectious Diseases is expected to drive the Global Gene
Synthesis Market growth in the forecast period, 2024-2028.
According to TechSci Research report, “Gene
Synthesis Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2028”, the Global Gene Synthesis Market stood
at USD 1.82 billion in 2022 with a CAGR of 9.24% through 2028.
Governments worldwide have initiated programs to
support the Gene Synthesis Market. These initiatives include funding research
projects related to genetics, genomics, and biotechnology, promoting
collaborations between academia and industry, and implementing regulations to
ensure responsible gene synthesis practices, biosecurity, and ethical
considerations. Additionally, governments may offer grants and incentives to
stimulate innovation and investment in gene synthesis technologies, fostering
economic growth and scientific advancements. These government efforts aim to
drive research, development, and commercialization in the gene synthesis field
while ensuring ethical and secure applications.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Gene
Synthesis Market”
The rising adoption of gene therapy has emerged as a
significant driver for the Gene Synthesis market, reshaping the landscape of
genetic research and biotechnology. This trend is driven by several key factors,
Gene therapy involves introducing specific genes into a patient's cells to
treat or prevent diseases. Gene synthesis plays a pivotal role by enabling the
custom design and synthesis of therapeutic gene constructs tailored to the
patient's condition. These constructs are critical components of viral vectors
or other delivery systems used in gene therapy. Gene therapy is at the forefront
of precision medicine, aiming to provide individualized treatments based on a
patient's genetic makeup. Gene synthesis facilitates the development of
patient-specific gene therapies by creating the necessary genetic material with
high precision. As gene therapy gains momentum as a promising therapeutic
approach for a range of diseases, including genetic disorders and certain
cancers, research efforts are intensifying. Gene synthesis accelerates R&D
by quickly providing researchers with the synthetic genes required for
experimental therapies, expediting the development process. Gene therapy is
increasingly being explored as a treatment for rare genetic disorders, where
custom-designed synthetic genes are crucial for addressing specific genetic
mutations or deficiencies. The Gene Synthesis market directly supports these
therapeutic advancements. The gene therapy field has attracted substantial
investment, including from biotech startups. These companies often rely on gene
synthesis services to develop and test their novel therapeutic candidates,
driving demand in the gene synthesis market.
Regulatory agencies are increasingly recognizing the
potential of gene therapy and streamlining approval processes. This supportive
regulatory environment encourages the development and commercialization of gene
therapies, bolstering the demand for gene synthesis services. The decreasing
cost of gene synthesis services makes personalized gene therapy more accessible
to a broader patient population. As gene therapies become more economically
viable, the market is poised for continued growth. In conclusion, the rising
adoption of gene therapy as a promising treatment modality across various
diseases has significantly boosted the demand for gene synthesis services. The
ability to create custom genetic constructs tailored to individual patients and
research needs is pivotal in advancing gene therapy and driving innovation
within the Gene Synthesis market.
The increased prevalence of chronic infectious
diseases has become a significant driver for the Gene Synthesis market,
influencing research, diagnostics, and therapeutic developments. Several
factors contribute to this phenomenon: The persistent rise in drug-resistant
strains of infectious pathogens, such as bacteria and viruses, poses a severe
global health threat. As conventional treatments become less effective, gene
synthesis plays a crucial role in designing custom solutions, including novel
antimicrobial peptides and drug targets. Researchers rely on synthesized genes
to develop innovative treatments to combat these resistant pathogens.
Chronic infectious diseases like HIV, hepatitis, and
tuberculosis require extensive research and vaccine development efforts. Gene
synthesis is indispensable for producing synthetic versions of viral or
bacterial genes, which are essential in the development, testing, and
production of vaccines. This technology expedites vaccine development in
response to emerging infectious threats. The accurate and early detection of
chronic infectious diseases is critical for effective disease management. Gene
synthesis contributes to the creation of diagnostic tools, such as PCR assays
and nucleic acid-based tests, that target specific genetic markers of
pathogens. These tools provide precise and rapid detection, aiding in timely
interventions. Gene therapy and genetic engineering hold promise for treating
chronic infectious diseases. Gene synthesis is instrumental in designing and
producing the genetic constructs necessary for gene editing, gene silencing, or
introducing therapeutic genes into patients. This personalized approach to
treatment is becoming increasingly relevant in managing chronic infections.
Gene synthesis facilitates the exploration of new
antiviral and antibiotic compounds. Researchers can design synthetic genes to
express candidate drug molecules, accelerating drug discovery processes. This
is particularly crucial in addressing chronic infections with limited treatment
options. International organizations and governments are increasingly focusing
on addressing chronic infectious diseases as part of global health initiatives.
These efforts often involve collaborations between research institutions and
gene synthesis providers to develop region-specific solutions. In conclusion,
the increased prevalence of chronic infectious diseases is driving demand for
gene synthesis services across various facets of research, diagnostics, and
therapeutics. As these diseases pose ongoing challenges to global health, gene
synthesis is central to the development of innovative solutions, further
solidifying its role in advancing efforts to combat chronic infectious diseases.
The Global Gene Synthesis Market is segmented into By Method,
Service, Application, End Use, Region, and company.
Based on the Method, The PCR-based enzyme segment is
poised for rapid growth during the forecast period in the gene synthesis market
due to several key factors. Firstly, polymerase chain reaction (PCR) is a
fundamental technique in molecular biology, widely used for DNA amplification
and manipulation. As the gene synthesis market expands, the demand for
high-quality, custom-designed DNA sequences increases. PCR-based enzymes,
including DNA polymerases and ligases, are indispensable tools for amplifying
and assembling these synthetic genes with precision and efficiency. Their
accuracy and fidelity in replicating DNA sequences are critical in ensuring the
functionality and reliability of synthesized genes, making them the preferred
choice for gene synthesis applications. Secondly, advancements in PCR
technology have led to the development of novel enzymes and polymerase variants
that offer enhanced performance, such as faster amplification and improved
fidelity. These innovations have expanded the capabilities of PCR-based
methods, further driving their adoption in gene synthesis.
Additionally, the increasing applications of gene
synthesis in areas like gene editing, molecular diagnostics, synthetic biology,
and gene therapy rely heavily on PCR-based enzymes. The versatility of
PCR-based techniques allows for a wide range of genetic manipulations, enabling
researchers to tailor DNA constructs for specific research or therapeutic
purposes. Furthermore, the trend towards personalized medicine and precision
biology underscores the importance of PCR-based enzymes in creating customized
genetic material for patient-specific treatments, driving their demand in the
healthcare sector. In summary, the PCR-based enzyme segment is expected to
experience rapid growth due to its essential role in gene synthesis, continual
technological advancements, expanding applications, and the increasing demand
for accurate and customized DNA sequences in various industries, making it a
key driver in the gene synthesis market's evolution.
Based on region, Asia Pacific is anticipated to
register the fastest growth in the gene synthesis market during the forecast
period due to several compelling factors that make the region a thriving hub
for biotechnology and genetic research. Firstly, Asia Pacific is home to a
rapidly expanding biotechnology sector. The region has witnessed significant
investments in research and development, biomanufacturing, and healthcare
infrastructure. These investments have created a conducive environment for the
gene synthesis market to flourish, as the demand for customized DNA constructs
for various applications continues to rise. Secondly, there is a growing focus
on genomics and precision medicine in Asia Pacific. Countries like China,
Japan, and South Korea have launched ambitious genomics projects, emphasizing
personalized healthcare solutions. Gene synthesis plays a pivotal role in
creating patient-specific genetic material for diagnostics and therapeutics,
aligning with the region's healthcare goals.
Furthermore, the region's large population provides a
vast patient pool for clinical trials and genetic research studies, increasing
the demand for gene synthesis services to support these initiatives.
Additionally, Asia Pacific's biotech startups and research institutions are
actively engaged in cutting-edge research projects that require custom-designed
DNA sequences, further fueling the gene synthesis market's growth. Moreover,
the region's favorable regulatory landscape and increasing collaborations between
academic institutions and industry players promote innovation and gene
synthesis adoption. Governments in Asia Pacific are also supporting the
biotechnology sector through funding and policy initiatives, stimulating market
expansion. In summary, Asia Pacific's robust biotechnology sector,
genomics-driven initiatives, population size, research activity, and supportive
policies position the region as a significant growth driver in the gene
synthesis market during the forecast period.
Major companies operating in Global Gene
Synthesis Market are:
- OriGene Technologies, Inc.
- Integrated DNA Technologies, Inc.
- ProMab Biotechnologies, Inc.
- Thermo Fisher Scientific, Inc.
- ProteoGenix, Inc.
- Biomatik USA LLC
- Twist Bioscience
- Boster Biological Technology
- Brooks Automation, Inc.
- Genscript Corp
- BEIJING GENOMICS INSTITUTE
Download
Free Sample Report
Customers can also request 10% free
customization on this report
“The gene synthesis market is expected to experience
significant growth in the coming years due to several factors. Advances in DNA
synthesis technologies have made custom gene design and production more
accessible and cost-effective, driving increased adoption across various
industries. Rising demand for personalized medicine, gene therapy, and
precision agriculture is fueling the need for tailored DNA sequences.
Additionally, the expansion of biotechnology applications and increased
investment in genetic research are contributing to the market's growth. As gene
synthesis continues to play a pivotal role in scientific and commercial
endeavors, it is poised to rise steadily in the foreseeable future.,” said Mr.
Karan Chechi, Research Director with TechSci Research, a research-based
management consulting firm.
“Gene Synthesis Market – Global Industry Size,
Share, Trends, Opportunity, and Forecast, 2018-2028 By Method (Solid-phase
Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis), By Service
(Antibody DNA Synthesis, Viral DNA Synthesis, Others), By Application (Gene
& Cell Therapy Development, Vaccine Development, Disease Diagnosis,
Others), By End Use (Biotechnology and Pharmaceutical Companies, Academic and
Government Research Institutes, Contract Research Organizations), By Region,
Competition”, has evaluated the future growth potential of Global Gene Synthesis
Market and provides statistics & information on market size, structure, and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Gene Synthesis
Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com